Qingke data: in October, 34 Chinese enterprises were listed, and the financing amount of biotechnology / medical health industry ranked first

Monthly review:

There are 34 listed Chinese enterprises at home and abroad, with a financing amount of 45.655 billion yuan

25 Chinese enterprises were supported by VC / PE Institutions, with a penetration rate of 73.5%

Liaoning Chengda Biotechnology Co.Ltd(688739) obtained the highest listing financing amount this month

The financing amount of six listed Chinese enterprises in Jiangsu Province ranked first, about 9.879 billion yuan

The CSRC issued the provisions on the supervision of initial public offering and listing guidance

According to the data of Zero2IPO Research Center under Zero2IPO venture (01945. HK), in October 2021, a total of 34 Chinese enterprises were listed in global trading markets, with a decrease compared with the previous month; the penetration rate of VC / PE was 73.5%; the total financing amount was 45.655 billion yuan, with a month on month increase of 5.6%. Biotechnology / medical health has become a hot industry this month, and the number of IPOs of Chinese enterprises on the gem ranks first. Liaoning Chengda Biotechnology Co.Ltd(688739) with a financing amount of RMB 4.582 billion, it has become the first enterprise listed in a single financing amount this month.

 

- Advertisment -